 Sean Iwamoto
Concepts (88)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Transgender Persons | 11 | 2024 | 172 | 5.100 |
Why?
| | Transsexualism | 4 | 2024 | 19 | 1.760 |
Why?
| | Sex Reassignment Surgery | 1 | 2024 | 8 | 0.910 |
Why?
| | Bone Diseases, Metabolic | 1 | 2024 | 57 | 0.830 |
Why?
| | Thromboembolism | 1 | 2024 | 112 | 0.810 |
Why?
| | Estradiol | 2 | 2024 | 494 | 0.760 |
Why?
| | Obesity Management | 1 | 2021 | 8 | 0.740 |
Why?
| | Osteitis Deformans | 1 | 2020 | 4 | 0.670 |
Why?
| | Osteolysis | 1 | 2020 | 18 | 0.660 |
Why?
| | Delivery of Health Care | 3 | 2023 | 894 | 0.650 |
Why?
| | Fractures, Compression | 1 | 2020 | 17 | 0.650 |
Why?
| | Obesity | 6 | 2024 | 2883 | 0.610 |
Why?
| | Spinal Fractures | 1 | 2020 | 81 | 0.610 |
Why?
| | Bariatric Surgery | 1 | 2021 | 193 | 0.580 |
Why?
| | Body Mass Index | 1 | 2024 | 2273 | 0.500 |
Why?
| | Physicians, Primary Care | 1 | 2018 | 230 | 0.490 |
Why?
| | Healthcare Disparities | 1 | 2021 | 578 | 0.460 |
Why?
| | Exercise | 1 | 2024 | 1925 | 0.410 |
Why?
| | Gender Identity | 4 | 2024 | 122 | 0.410 |
Why?
| | Hormones | 2 | 2022 | 140 | 0.360 |
Why?
| | Adult | 11 | 2024 | 35576 | 0.350 |
Why?
| | Cardiovascular Diseases | 1 | 2021 | 2004 | 0.310 |
Why?
| | Male | 15 | 2024 | 63681 | 0.310 |
Why?
| | Primary Health Care | 1 | 2018 | 1680 | 0.290 |
Why?
| | Female | 15 | 2024 | 68776 | 0.280 |
Why?
| | Weight Loss | 3 | 2021 | 734 | 0.270 |
Why?
| | Humans | 17 | 2024 | 129650 | 0.250 |
Why?
| | Gender Dysphoria | 1 | 2024 | 19 | 0.230 |
Why?
| | Endocrinologists | 1 | 2024 | 12 | 0.220 |
Why?
| | Injections, Subcutaneous | 1 | 2024 | 147 | 0.220 |
Why?
| | Injections, Intramuscular | 1 | 2024 | 116 | 0.220 |
Why?
| | Sports Medicine | 1 | 2024 | 110 | 0.200 |
Why?
| | Periodicals as Topic | 1 | 2024 | 204 | 0.190 |
Why?
| | Sports | 1 | 2024 | 225 | 0.190 |
Why?
| | Cardiology | 1 | 2024 | 261 | 0.180 |
Why?
| | Testosterone | 1 | 2024 | 372 | 0.170 |
Why?
| | Surveys and Questionnaires | 3 | 2023 | 5406 | 0.170 |
Why?
| | Receptor Activator of Nuclear Factor-kappa B | 1 | 2020 | 8 | 0.170 |
Why?
| | RANK Ligand | 1 | 2020 | 26 | 0.170 |
Why?
| | Sexual and Gender Minorities | 1 | 2023 | 194 | 0.160 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2024 | 2012 | 0.160 |
Why?
| | Weight Gain | 1 | 2023 | 510 | 0.160 |
Why?
| | Anti-Obesity Agents | 1 | 2019 | 53 | 0.160 |
Why?
| | Health Status | 1 | 2024 | 755 | 0.150 |
Why?
| | Weight Reduction Programs | 1 | 2019 | 111 | 0.150 |
Why?
| | Progesterone | 1 | 2019 | 245 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2024 | 758 | 0.130 |
Why?
| | Sexual Behavior | 1 | 2019 | 483 | 0.120 |
Why?
| | Mass Screening | 1 | 2021 | 1149 | 0.100 |
Why?
| | Middle Aged | 3 | 2020 | 31154 | 0.080 |
Why?
| | Cross-Sectional Studies | 1 | 2018 | 5066 | 0.070 |
Why?
| | Risk Factors | 1 | 2021 | 9765 | 0.070 |
Why?
| | Amyloid beta-Peptides | 1 | 2006 | 213 | 0.060 |
Why?
| | Health Services for Transgender Persons | 1 | 2022 | 2 | 0.050 |
Why?
| | Peptide Fragments | 1 | 2006 | 692 | 0.050 |
Why?
| | Mitochondria | 1 | 2006 | 877 | 0.040 |
Why?
| | Policy | 1 | 2021 | 144 | 0.040 |
Why?
| | Self Report | 1 | 2023 | 799 | 0.040 |
Why?
| | History, 21st Century | 1 | 2019 | 183 | 0.040 |
Why?
| | Safety-net Providers | 1 | 2019 | 109 | 0.040 |
Why?
| | Neurons | 1 | 2006 | 1511 | 0.040 |
Why?
| | Apoptosis | 1 | 2006 | 2503 | 0.040 |
Why?
| | Gene Expression Regulation | 1 | 2006 | 2548 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2019 | 241 | 0.030 |
Why?
| | Curriculum | 1 | 2023 | 917 | 0.030 |
Why?
| | Urban Population | 1 | 2019 | 441 | 0.030 |
Why?
| | Cohort Studies | 1 | 2019 | 5420 | 0.020 |
Why?
| | Fura-2 | 1 | 2006 | 20 | 0.020 |
Why?
| | bcl-2-Associated X Protein | 1 | 2006 | 55 | 0.020 |
Why?
| | Cytochromes c | 1 | 2006 | 60 | 0.020 |
Why?
| | In Situ Nick-End Labeling | 1 | 2006 | 124 | 0.020 |
Why?
| | Cyclin D1 | 1 | 2006 | 63 | 0.020 |
Why?
| | Retrospective Studies | 1 | 2024 | 14518 | 0.020 |
Why?
| | Cell Count | 1 | 2006 | 314 | 0.020 |
Why?
| | Cytoplasm | 1 | 2006 | 263 | 0.020 |
Why?
| | Embryo, Mammalian | 1 | 2006 | 226 | 0.020 |
Why?
| | Drug Interactions | 1 | 2006 | 394 | 0.010 |
Why?
| | Adolescent | 1 | 2024 | 20393 | 0.010 |
Why?
| | Child | 1 | 2024 | 20883 | 0.010 |
Why?
| | Blotting, Western | 1 | 2006 | 1205 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2006 | 672 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2006 | 1698 | 0.010 |
Why?
| | Hippocampus | 1 | 2006 | 874 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2006 | 2406 | 0.010 |
Why?
| | Calcium | 1 | 2006 | 1213 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2006 | 4083 | 0.010 |
Why?
| | Rats | 1 | 2006 | 5500 | 0.010 |
Why?
| | Animals | 1 | 2006 | 35361 | 0.000 |
Why?
|
|
Iwamoto's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|